Whole Genome Sequencing and in vitro analyses highlight the production of folate and the antimicrobial properties of Lacticaseibacillus rhamnosus SL42.

preprint OA: closed CC-BY-4.0

Abstract

Lacticaseibacillus rhamnosus SL42 is a probiotic strain isolated Whole Genome Sequencing (WGS) and in vitro analyses were used to assess the probiotic potential of Lacticaseibacillus rhamnosus SL42, a breast milk isolate, for B-vitamin production and antimicrobial property. Genomic analysis found genes involved in vitamin B9 biosynthesis and defense mechanisms, indicating the strain's potential for use in food biotechnology. This was supported by in vitro confirmations. SL42 was able to synthesize folate in milk, demonstrating the functioning of the coding genes. PathogenFinder discovered that the strain lacks the pathogenic-associated genes; suggesting its suitability as a probiotic and biofortifying agent in food products. Furthermore, a plethora of coding genes annotated for defense and adaptability to numerous harsh conditions, as well as functional properties associated with antioxidant activity and bioremediation, were discovered. The strain reflects an exceptional adaptability in a multiplicity of situations, most specifically cold-chain storages. In general, SL42's beneficial role has been linked to different biotechnological and therapeutic applications mainly B-vitamin biofortification, immune diseases, and neurodegenerative disorders.
Full text 1,467 characters · extracted from oa-doi-fallback · click to expand
Full text loading... Abstract Lacticaseibacillus rhamnosus SL42 is a probiotic strain isolated Whole Genome Sequencing (WGS) and in vitro analyses were used to assess the probiotic potential of Lacticaseibacillus rhamnosus SL42, a breast milk isolate, for B-vitamin production and antimicrobial property. Genomic analysis found genes involved in vitamin B9 biosynthesis and defense mechanisms, indicating the strain's potential for use in food biotechnology. This was supported by in vitro confirmations. SL42 was able to synthesize folate in milk, demonstrating the functioning of the coding genes. PathogenFinder discovered that the strain lacks the pathogenic-associated genes; suggesting its suitability as a probiotic and biofortifying agent in food products. Furthermore, a plethora of coding genes annotated for defense and adaptability to numerous harsh conditions, as well as functional properties associated with antioxidant activity and bioremediation, were discovered. The strain reflects an exceptional adaptability in a multiplicity of situations, most specifically cold-chain storages. In general, SL42's beneficial role has been linked to different biotechnological and therapeutic applications mainly B-vitamin biofortification, immune diseases, and neurodegenerative disorders. - Received: - Version Posted: Funding - Algerian Ministry of Higher Education and Scientific Research (Award DOOL01UN270120230003) - Principal Award Recipient: Hasnia Ziar

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0